Triventures is a venture capital fund focused on investing in medical device and digital health technologies from seed stage to industry leaders. The firm has over $100 million under management dedicated to ventures primarily in Israel and the U.S.
11 Hasadnaot St.
Sea View Building #B, 5th Floor
|2018-06-19||LifeBEAM||Series B||$20M||Cerca Partners, FGI Capital Partners, Joy Ventures, New Era Ventures, Square Peg Capital, and Wellborn Venture|
|2018-05-15||Genoox||Series B||$6M||Glilot Capital Partners, and Inimiti Capital Partners|
|2018-04-26||V-Wave||Series C||$70M||Aperture Venture Partners, BioStar Ventures, BRM Group, Deerfield Management, Edwards Lifesciences, Endeavour Vision, Israel Secondary Fund, Johnson & Johnson Innovation, Pontifax, Pura Vida Investments, and Quark Venture|
|2017-10-02||CathWorks||Series B||$15.8M||BioStar Ventures, Corundum Open Innovation, GF Securities, Planven Investments, Pontifax, and Quark Venture|
|2017-09-27||Colospan||Series A||$7.7M||Alfred Mann Institute at the Technion, Clal Biotechnology Industries, and Docor International Management|